Unknown

Dataset Information

0

On-Chip Preconcentration Microchip Capillary Electrophoresis Based CE-PRM-LIVE for High-Throughput Selectivity Profiling of Deubiquitinase Inhibitors.


ABSTRACT: The family of deubiquitinases (DUBs) comprises ∼100 enzymes that cleave ubiquitin from substrate proteins and thereby regulate key aspects of human physiology. DUBs have recently emerged as disease-relevant and chemically tractable, although currently there are no approved DUB-targeting drugs and most preclinical small molecules are low-potency and/or multitargeted. We paired a novel capillary electrophoresis microchip containing an integrated, "on-chip" C18 bed (SPE-ZipChip) with a TMT version of our recently described PRM-LIVE acquisition scheme on a timsTOF Pro mass spectrometer to facilitate rapid activity-based protein profiling of DUB inhibitors. We demonstrate the ability of the SPE-ZipChip to improve proteome coverage of complex samples as well as the quantitation integrity of CE-PRM-LIVE for TMT labeled samples. These technologies provide a platform to accurately quantify competitive binding of covalent and reversible inhibitors in a multiplexed assay that spans 49 endogenous DUBs in less than 15 min.

SUBMITTER: Zhu H 

PROVIDER: S-EPMC10654755 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

On-Chip Preconcentration Microchip Capillary Electrophoresis Based CE-PRM-LIVE for High-Throughput Selectivity Profiling of Deubiquitinase Inhibitors.

Zhu He H   Mellors J Scott JS   Chan Wai Cheung WC   Thompson J Will JW   Ficarro Scott B SB   Tavares Isidoro I   Bratt Ariana S AS   Decker Jens J   Krause Michael M   Kruppa Gary G   Buhrlage Sara J SJ   Marto Jarrod A JA  

Analytical chemistry 20220621 27


The family of deubiquitinases (DUBs) comprises ∼100 enzymes that cleave ubiquitin from substrate proteins and thereby regulate key aspects of human physiology. DUBs have recently emerged as disease-relevant and chemically tractable, although currently there are no approved DUB-targeting drugs and most preclinical small molecules are low-potency and/or multitargeted. We paired a novel capillary electrophoresis microchip containing an integrated, "on-chip" C18 bed (SPE-ZipChip) with a TMT version  ...[more]

Similar Datasets

2022-03-24 | MSV000089122 | MassIVE
| S-EPMC7917630 | biostudies-literature
| S-EPMC5516626 | biostudies-literature
| S-EPMC1592466 | biostudies-other
| S-EPMC4470751 | biostudies-literature
| S-EPMC9230880 | biostudies-literature
| S-EPMC4128283 | biostudies-literature
| S-EPMC5915312 | biostudies-literature
| S-EPMC3031587 | biostudies-literature
| S-EPMC5670189 | biostudies-literature